Publications by authors named "N A Gray"

Neuroinflammation and mitochondrial dysfunction are early events in Alzheimer's disease (AD) and contribute to neurodegeneration and cognitive impairment. Evidence suggests that the inflammatory axis mediated by macrophage migration inhibitory factor (MIF) binding to its receptor, CD74, plays an important role in many central nervous system (CNS) disorders such as AD. Our group has developed DRhQ, a novel CD74 binding construct which competitively inhibits MIF binding, blocks macrophage activation and migration into the CNS, enhances anti-inflammatory microglia cell numbers and reduces pro-inflammatory gene expression.

View Article and Find Full Text PDF

(L.) Urban (family Apiaceae) () is a traditional botanical medicine used in aging and dementia. Water extracts of (CAW) have been used to treat neuropsychiatric symptoms in related animal models and are associated with increases in antioxidant response element (ARE) genes and improvements in mitochondrial respiratory function and neuronal health.

View Article and Find Full Text PDF

Kirsten rat sarcoma viral oncogene homolog (KRAS) is the most frequently mutated oncogene in lung adenocarcinoma, with G12C and G12V being the most predominant forms. Recent breakthroughs in KRASG12C inhibitors have transformed the clinical management of patients with the G12C mutation and advanced our understanding of the function of this mutation. However, little is known about the targeted disruption of KRASG12V, partly due to a lack of specific inhibitors.

View Article and Find Full Text PDF
Article Synopsis
  • Current Focus
  • : The article informs neurologists about available cerebrospinal fluid (CSF) and plasma biomarkers for diagnosing dementia and making treatment decisions based on those diagnoses.
  • Recent Advances
  • : The FDA's approval of monoclonal antibody therapy for Alzheimer’s underscores a need for accurate biomarker confirmation before treatment. New blood-based biomarkers and a CSF assay for α-synuclein in Lewy body dementia are noteworthy developments.
  • Future Directions
  • : Established CSF biomarkers exist for various dementias, but emerging blood-based biomarkers are evolving and improving in accuracy. It's crucial to validate these blood biomarkers for therapy monitoring since current CSF testing isn't practical.
View Article and Find Full Text PDF

Background: A water extract of the Ayurvedic plant (CAW) improves cognitive function in mouse models of aging and Alzheimer's disease, and affects dendritic arborization, mitochondrial activity and oxidative stress in mouse primary neurons. Triterpenes (TT) and caffeoylquinic acids (CQA) are constituents associated with these bioactivities of CAW although little is known about how interactions between these compounds contribute to the plant's therapeutic benefit.

Methods: Mouse primary cortical neurons were treated with CAW, or equivalent concentrations of four TT combined, eight CQA combined, or these twelve compounds combined (TTCQA).

View Article and Find Full Text PDF